As biotech market remains chilly, Longeveron CEO steps down after 18-month run
The Longeveron CEO who helped take the biotech public is now set to resign.
Geoff Green, Longeveron’s chief executive since November 2020, will step down …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
